No Data
No Data
GlaxoSmithKline (GSK) Gets a Hold From Barclays
GSK Announced Headline Results From FIRST-ENGOT-OV44 Phase 3 Trial Of Zejula (Niraparib) And Jemperli (Dostarlimab) In First Line Advanced Ovarian Cancer, The Trial Met Its Primary Endpoint Of Progression-free Survival, The Key Secondary Endpoint Of...
GSK's Combination of Cancer Drugs Shows Positive Results in Late-Stage Trial
GSK's Ovarian Cancer Treatment Meets Primary Endpoint in Late-stage Study
Your Healthcare Costs Are Soaring! US Spending Reached $5 Trillion In 2023 With Major Increase in Obesity and Diabetes Drugs, Hospital Services
GlaxoSmithKline (GSK) Gets a Hold From Goldman Sachs
Unlock the Full List